Deep Vein Thrombosis Support Groups

Links shared publicly online about this topic

Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism

physorg.com — “Three critical recommendations from a national workshop have been released to address deep-vein thrombosis (DVT) and pulmonary embolism (PE), a growing public health problem estimated to affect nearly 1 million Americans each year. The recommendations - developed by a diverse group of representatives ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on March 9, 2010 at 9:40 pm By:

physorg_health PhysOrg Health News Health News

Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism http://tw.physorg.com/187373574

2 years ago...

JAMA -- Updated Analysis of Gene Variants Associated With Deep Vein Thrombosis, February 3, 2010, Bezemer et al. 303 (5): 421

jama.ama-assn.org — “JAMA is a highly cited weekly medical journal that publishes peer-reviewed original medical research findings and editorial opinionView full resource at jama.ama-assn.org

  • View Related
  • Share

Most Recently Shared on February 2, 2010 at 10:00 pm By:

JAMA_current JAMA Medical Journal

Updated Analysis of Gene Variants Associated With Deep Vein Thrombosis [Research Letters] http://bit.ly/bx0jLb

2 years ago...

Blood clot risk for men with prostate cancer | Life and style | BMJ Group

guardian.co.uk — “Prostate cancer, and some treatments for prostate cancer, may increase men's risk of getting a dangerous blood clot, new research showsView full resource at guardian.co.uk

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 5:05 pm By:

prostatecancer_ Prostate Cancer Support

Blood clot risk for men with prostate cancer http://bit.ly/9JX7EF

2 years ago...

Pulse Therapeutics receives fund to develop novel magnetics technique to destroy blood clots

news-medical.net — “BioGenerator, a non-profit, seed-stage economic development funding group, today announced that it has led a round of early-stage financing for Pulse Therapeutics, Inc., a St. Louis company headquartered at the Center for Emerging Technologies. Pulse Therapeutics develops innovative magnetism-based technology to safely destroy blood clots related to ischemic stroke and deep vein thrombosis (DVT). Other investors who participated in the round were Missouri Technology Corporation (MTC), WashingtonView full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 12, 2010 at 10:48 am By:

Stroke_News News-Medical.Net Health News

Stroke News: Pulse Therapeutics receives fund to develop novel magnetics technique to destroy blood clots: BioGe... http://twurl.nl/7eivwf

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • physorg_health

    PhysOrg Health News

    PhysOrg.com Health and Medicine News Stories

    View Profile

  • JAMA_current

    JAMA

    The Journal of the American Medical Association, published since 1883, is an international peer-reviewed general medical journal published 48 times per year.

    View Profile

  • prostatecancer_

    Prostate Cancer

    You just hit the official Twitter Page of Prostate Cancer Community! We have the info you need when it come to Prostate Cancer. Dive in and get connected!

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390